Plain-English translation of NCT06402968 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing clevidipine, an intravenous (IV) blood pressure medication that works quickly, in people who have experienced acute intracerebral hemorrhage—a type of stroke caused by bleeding in the brain. Researchers want to see if clevidipine can lower dangerously high blood pressure faster and more safely than other standard IV blood pressure medications currently used in hospitals. The study will compare how quickly patients reach their target blood pressure and remain stable when treated with clevidipine versus other IV medications.
When someone has a bleeding stroke, high blood pressure can make the bleeding worse and cause more brain damage. While doctors know that controlling blood pressure is important, they're not yet sure which medication works best to bring it down quickly and safely without causing harm. This study will help answer that question.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be admitted to a hospital that is part of this study. You will receive either clevidipine or an alternative IV blood pressure medication as standard care for your brain bleed. Hospital staff will monitor your blood pressure closely over the first hour to see how quickly the medication brings it under control. You will also have follow-up visits at 90 days and 180 days after your stroke to assess your recovery and long-term outcomes.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States